SE
Samuel Ellis
UCL Institute of Child Health, University College London, Quadram Institute, University of East Anglia
Research areas: Medicine · Infectious Diseases · SARS-CoV-2 and COVID-19 Research · COVID-19 Clinical Research Studies · SARS-CoV-2 detection and testing
0000-0002-5012-4277
Employment
-
UCL Institute of Child Health Research Fellow2019 - Present
Education
- 2014 - 2018
-
University of East Anglia MSc in Molecular Medicine2013 - 2014
-
University of East Anglia BSc in Biochemistry2010 - 2013
Projects & Funding
Projects & funding information is unavailable.
Publications (23)
- Neutrophil myeloperoxidase as a functional biomarker for RSV severity: implications for in vitro therapeutic screening Save
- Polymerase-inhibitor drug synergy and mutational signatures in different epithelial cell models of RSVA and hPIV3 infection. Save
- Donor-derived airway ALI model for high-throughput screening of antiviral combinations with concurrent analysis of antiviral efficacy and epithelial toxicity using ciliR Save
- Nirmatrelvir-ritonavir versus usual care in at-risk adults with early SARS-CoV-2 infection in the UK, 2022-23: virological and immunological results of an open-label randomised trial (PANORAMIC) Save
- Antiviral drug synergy and mutational signatures in different epithelial cell models of RSV and hPIV infection Save
- Design and development of a SARS and MERS Combination Vaccine Save
- A Viroimmunologic Model to Characterize the Antiviral Effect of Molnupiravir in Outpatients Infected With SARS-CoV-2: Implication for Treatment Duration Save
- Efficient in vitro assay for evaluating drug efficacy and synergy against emerging SARS-CoV-2 strains Save
- Neutrophil myeloperoxidase as a functional biomarker for RSV severity: implications for in vitro therapeutic screening Save
- Author Correction: Age-specific nasal epithelial responses to SARS-CoV-2 infection Save
- Human SARS-CoV-2 challenge uncovers differences in local and systemic cellular responses associated with protection from infection and distinct infection states Save
- Author Correction: Human SARS-CoV-2 challenge uncovers local and systemic response dynamics Save
- Human SARS-CoV-2 challenge uncovers local and systemic response dynamics Save
- Age-specific nasal epithelial responses to SARS-CoV-2 infection Save
- Randomized controlled trial of molnupiravir SARS-CoV-2 viral and antibody response in at-risk adult outpatients. Save
- Salivary IgA and vimentin differentiate in vitro SARS-CoV-2 infection: A of 290 convalescent COVID-19 Save
- The emergence of goblet inflammatory or ITGB6hi nasal progenitor cells determines age-associated SARS-CoV-2 pathogenesis Save
- Longevity and neutralisation activity of secretory IgA following SARS-CoV-2 infection Save
- Identification and characterisation of enteroaggregative Escherichia coli subtypes associated with human disease Save
- Oxygen and contact with human intestinal epithelium independently stimulate virulence gene expression in enteroaggregative Escherichia coli Save